These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32586663)

  • 1. Chronic Active Antibody-Mediated Rejection With Donor-Specific Anti-HLA-DP Antibodies Following Living Donor Kidney Transplantation: A Case Report.
    Fukuoka K; Tokodai K; Miyagi S; Nakanishi W; Nishimura R; Fujio A; Watanabe H; Taniuchi S; Naitoh T; Ishida T; Unno M; Kamei T
    Transplant Proc; 2020; 52(6):1937-1939. PubMed ID: 32586663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.
    Bachelet T; Martinez C; Del Bello A; Couzi L; Kejji S; Guidicelli G; Lepreux S; Visentin J; Congy-Jolivet N; Rostaing L; Taupin JL; Kamar N; Merville P
    Transplantation; 2016 Jan; 100(1):159-66. PubMed ID: 26262501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and impact of anti-HLA-DP antibodies in renal transplantation.
    Hörmann M; Dieplinger G; Rebellato LM; Briley KP; Bolin P; Morgan C; Haisch CE; Everly MJ
    Clin Transplant; 2016 Sep; 30(9):1108-14. PubMed ID: 27327607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-Mediated Rejection Due to Donor-Specific HLA-DQB1 and DQA1 Antibodies After Kidney Transplantation: A Case Report.
    Thammanichanond D; Tammakorn C; Worawichawong S; Kantachuvesiri S
    Transplant Proc; 2020; 52(6):1931-1936. PubMed ID: 32444122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Antibody-Mediated Rejection by De Novo Anti-HLA-DPβ and -DPα Antibodies After Kidney Transplantation: A Case Report.
    Thammanichanond D; Parapiboon W; Mongkolsuk T; Worawichawong S; Tammakorn C; Kitpoka P
    Transplant Proc; 2018 Oct; 50(8):2548-2552. PubMed ID: 30316396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late antibody-mediated rejection by de novo donor HLA-DP-specific antibody after renal transplantation: a case report.
    Cippà PE; Gaspert A; Etter C; Guenduez Z; Ferrari-Lacraz S; Rüsi B; Fehr T
    Hum Immunol; 2014 May; 75(5):462-5. PubMed ID: 24530822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and Qs.
    Cross AR; Lion J; Loiseau P; Charron D; Taupin JL; Glotz D; Mooney N
    Hum Immunol; 2016 Nov; 77(11):1092-1100. PubMed ID: 27060781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of Human Leukocyte Antigens and Donor Specific Antibodies in Long-Term Living Donor Kidney Transplantation.
    Alagoz S; Seyahi N
    Transplant Proc; 2019 Sep; 51(7):2302-2307. PubMed ID: 31358448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of preformed and de novo anti-HLA DP antibodies in renal allograft survival.
    Redondo-Pachón D; Pascual J; Pérez-Sáez MJ; García C; Hernández JJ; Gimeno J; Mir M; Crespo M
    Transpl Immunol; 2016 Feb; 34():1-7. PubMed ID: 26603314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP.
    Mierzejewska B; Schroder PM; Baum CE; Blair A; Smith C; Duquesnoy RJ; Marrari M; Gohara A; Malhotra D; Kaw D; Liwski R; Rees MA; Stepkowski S
    Hum Immunol; 2014 Aug; 75(8):703-8. PubMed ID: 24755353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation.
    Thaunat O; Hanf W; Dubois V; McGregor B; Perrat G; Chauvet C; Touraine JL; Morelon E
    Transpl Immunol; 2009 Mar; 20(4):209-11. PubMed ID: 19166936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preformed donor HLA-DP-specific antibodies mediate acute and chronic antibody-mediated rejection following renal transplantation.
    Jolly EC; Key T; Rasheed H; Morgan H; Butler A; Pritchard N; Taylor CJ; Clatworthy MR
    Am J Transplant; 2012 Oct; 12(10):2845-8. PubMed ID: 22759079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rises and falls in donor-specific and third-party HLA antibody levels after antibody incompatible transplantation.
    Higgins R; Lowe D; Hathaway M; Lam F; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Zehnder D; Briggs D
    Transplantation; 2009 Mar; 87(6):882-8. PubMed ID: 19300192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations.
    Dieplinger G; Ditt V; Arns W; Huppertz A; Kisner T; Hellmich M; Bauerfeind U; Stippel DL
    Transpl Int; 2014 Jan; 27(1):60-8. PubMed ID: 24131087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.
    Marfo K; Ajaimy M; Colovai A; Kayler L; Greenstein S; Lubetzky M; Gupta A; Kamal L; de Boccardo G; Masiakos P; Kinkhabwala M; Akalin E
    Transplantation; 2014 Nov; 98(10):1082-8. PubMed ID: 24873780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
    Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplant anti-HLA-Cw and anti-HLA-DP antibodies in sensitized patients.
    Ling M; Marfo K; Masiakos P; Aljanabi A; Lindower J; Glicklich D; de Boccardo G; Greenstein S; Chapochnick-Friedmann J; Kayler L; Kinkhabwala M; Akalin E
    Hum Immunol; 2012 Sep; 73(9):879-83. PubMed ID: 22841893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
    Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
    Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-mediated rejection due to anti-HLA-DQ antibody after pregnancy and delivery in a female kidney transplant recipient.
    Sagasaki M; Nakada Y; Yamamoto I; Kawabe M; Yamakawa T; Katsumata H; Mafune A; Katsuma A; Kobayashi A; Koike K; Koike Y; Miki J; Yamada H; Kimura T; Tanno Y; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():81-84. PubMed ID: 29968405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single center observation of the role of pre-existing HLA-DP antibodies in humoral rejection following renal transplantation.
    Nikaein A; Lerman M; Rofaiel G; Allam SR
    Transpl Immunol; 2018 Dec; 51():58-61. PubMed ID: 30237092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.